ScholarGate
Asistents

Salīdzināt metodes

Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.

CHA₂DS₂-VASc Score×CURB-65 pneimonijas smaguma rādītājs×qSOFA rādītājs×
NozareKlīniskā novērtēšanaKlīniskā novērtēšanaKlīniskā novērtēšana
SaimeProcess / pipelineProcess / pipelineProcess / pipeline
Izcelsmes gads201020032016
AutorsGregory Y. H. Lip, Robby Nieuwlaat, et al.W. Staniford Lim, et al.Sepsis-3 Taskforce
TipsAtrial fibrillation stroke risk stratificationCommunity-acquired pneumonia severity assessmentRapid sepsis screening
PirmavotsLip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382. DOI ↗Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810. DOI ↗
Citi nosaukumiCHA2DS2VASc, Atrial fibrillation stroke riskCURB-65, Pneumonia severityQuick SOFA, qSOFA
Saistītās333
KopsavilkumsThe CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.
ScholarGateDatu kopa
  1. v1
  2. 2 Avoti
  3. PUBLISHED
  1. v1
  2. 2 Avoti
  3. PUBLISHED
  1. v1
  2. 2 Avoti
  3. PUBLISHED

Doties uz meklēšanu Lejupielādēt slaidus

ScholarGateSalīdzināt metodes: CHA₂DS₂-VASc Score · CURB-65 Pneumonia Severity Score · qSOFA Score. Izgūts 2026-06-19 no https://scholargate.app/lv/compare